(Q37962869)

26 August 2017

title

Prospects in radionuclide imaging of prostate cancer (English)

1 reference

26 August 2017

1 reference

2

Otto C Boerman

1 reference

26 August 2017

6

Wim J G Oyen

1 reference

26 August 2017

1

Susanne Lütje

1 reference

26 August 2017

5

Wijnand Helfrich

1 reference

26 August 2017

3

Catharina M van Rij

1 reference

26 August 2017

7

Peter F A Mulders

1 reference

26 August 2017

Michiel Sedelaar

4

1 reference

26 August 2017

publication date

29 November 2011

1 reference

26 August 2017

1 reference

26 August 2017

volume

72

1 reference

26 August 2017

issue

11

1 reference

26 August 2017

page(s)

1262-1272

1 reference

Estimates of cancer incidence and mortality in Europe in 2008.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Imaging localized prostate cancer: current approaches and new developments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Technological advances in radiation therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Radionuclide and hybrid imaging of recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Imaging prostate cancer: a multidisciplinary perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Endorectal color doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Imaging techniques for prostate cancer: implications for focal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Mitochondrial function, zinc, and intermediary metabolism relationships in normal prostate and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Contribution of the MR spectroscopic imaging in the diagnosis of prostate cancer in the peripheral zone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Synthesis of bombesin-functionalized iron oxide nanoparticles and their specific uptake in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Nuclear medicine studies of the prostate, testes, and bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Early response assessment in prostate carcinoma by 18F-fluorothymidine following anticancer therapy with docetaxel using preclinical tumour models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

PET/CT Imaging and Radioimmunotherapy of Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

[11C]Choline as a PET biomarker for assessment of prostate cancer tumor models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Visualization of prostate cancer with 11C-choline positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Novel tracers and their development for the imaging of metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

(11)C-acetate PET in the early evaluation of prostate cancer recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Imaging of prostate cancer metastases with 18F-fluoroacetate using PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Positron emission tomography and bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

2-18F-Fluoropropionic acid as a PET imaging agent for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Positron tomographic assessment of androgen receptors in prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7–14)NH2], in a prostate tumor xenografted mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

99mTc-bombesin detects prostate cancer and invasion of pelvic lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Role of 99mTc-bombesin scan in diagnosis and staging of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

The role of alpha(v)beta(3) in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

18F-labeled BBN-RGD heterodimer for prostate cancer imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Small-animal PET of tumors with (64)Cu-labeled RGD-bombesin heterodimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Technology insight: monoclonal antibody imaging of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Impact of fusion of indium-111 capromab pendetide volume data sets with those from MRI or CT in patients with recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

High-resolution animal PET imaging of prostate cancer xenografts with three different 64Cu-labeled antibodies against native cell-adherent PSMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Targeting Metastatic Prostate Cancer With Radiolabeled Monoclonal Antibody J591 to the Extracellular Domain of Prostate Specific Membrane Antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Prostate stem cell antigen is overexpressed in prostate cancer metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Targeting, imaging, and therapy using a humanized antiprostate stem cell antigen (PSCA) antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Humanized radioiodinated minibody for imaging of prostate stem cell antigen-expressing tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Targeting prostate cancer cells in vivo using a rapidly internalizing novel human single-chain antibody fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Positron emission tomography imaging of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22462

21 January 2018

Identifiers

DOI

10.1002/PROS.22462

1 reference

26 August 2017

1 reference